» Articles » PMID: 6376105

The Alveolar Macrophage

Overview
Date 1984 Apr 1
PMID 6376105
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The pulmonary macrophagic system is critical to the defense of the lung, keeping the alveoli clean and sterile and responding on demand with an adaptive outpouring of new cells into the air sacs. Under basal conditions alveolar macrophages, in common with other mononuclear phagocytes, are derived from the bone marrow. A population of macrophage precursors within the pulmonary interstitium provides a reserve pool capable of proliferation and delivery of phagocytes in response to unusually heavy loads of inhaled particles. This reserve system also produces macrophages when monocytic precursors in the bone marrow are depleted by diseases such as leukemia. The alveolar macrophage is destined to ingest particulate matter and to be eliminated along the mucociliary pathway; clearance by lymphatics is of minor importance and macrophages probably do not recross the alveolar epithelium to reach the pulmonary interstitial compartment. Although the protective role of the macrophage is dominant, this cell may participate, directly or indirectly, in the genesis of two major groups of chronic pulmonary disease, interstitial fibrosis and emphysema. Such inappropriate responses involve interactions with fibroblastic cells and tissue injury initiated by proteases secreted by the macrophage.

Citing Articles

Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects.

Zheng M, Zhu W, Gao F, Zhuo Y, Zheng M, Wu G J Nanobiotechnology. 2024; 22(1):136.

PMID: 38553716 PMC: 10981316. DOI: 10.1186/s12951-024-02407-6.


Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis.

Zheng M, Liu K, Li L, Feng C, Wu G J Nanobiotechnology. 2024; 22(1):14.

PMID: 38166847 PMC: 10763202. DOI: 10.1186/s12951-023-02251-0.


Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells.

Morgun E, Zhu J, Almunif S, Bobbala S, Aguilar M, Wang J Elife. 2023; 12.

PMID: 37877801 PMC: 10599656. DOI: 10.7554/eLife.87431.


Immunometabolism of Immune Cells in Mucosal Environment Drives Effector Responses against .

Tukiman M, Norazmi M Int J Mol Sci. 2022; 23(15).

PMID: 35955665 PMC: 9369211. DOI: 10.3390/ijms23158531.


Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Seyfoori A, Shokrollahi Barough M, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A Int J Mol Sci. 2021; 22(13).

PMID: 34203268 PMC: 8269337. DOI: 10.3390/ijms22136937.


References
1.
Pinkett M, COWDREY C, Nowell P . Mixed hematopoietic and pulmonary origin of 'alveolar macrophages' as demonstrated by chromosome markers. Am J Pathol. 1966; 48(5):859-67. PMC: 1907262. View

2.
HEPPLESTON A, Styles J . Activity of a macrophage factor in collagen formation by silica. Nature. 1967; 214(5087):521-2. DOI: 10.1038/214521a0. View

3.
Kilburn K . A hypothesis for pulmonary clearance and its implications. Am Rev Respir Dis. 1968; 98(3):449-63. DOI: 10.1164/arrd.1968.98.3.449. View

4.
Suzuki Y, Churg J . Structure and development of the asbestos body. Am J Pathol. 1969; 55(1):79-107. PMC: 2013380. View

5.
BOWDEN D, Adamson I, Grantham W, WYATT J . Origin of the lung macrophage. Evidence derived from radiation injury. Arch Pathol. 1969; 88(5):540-6. View